Literature DB >> 18991886

Toluene and TCE decrease binding to mu-opioid receptors, but not to benzodiazepine and NMDA receptors in mouse brain.

N Páez-Martínez1, E Ambrosio, C García-Lecumberri, L Rocha, G L Montoya, S L Cruz.   

Abstract

In vitro and in vivo studies have shown that abused solvents affect different neurotransmitter systems, including the GABAergic, glutamatergic, and opioidergic. The first purpose of this study was to determine in mice whether an acute exposure to 4,000 ppm toluene or 12,000 ppm 1,1,1-trichloroethane (TCE) modifies receptor binding levels to: (a) DAMGO, a mu-opioid receptor selective agonist; (b) MK-801, a noncompetitive selective NMDA-receptor antagonist; and (c) flunitrazepam, a benzodiazepine binding site selective agonist. In addition, in separate groups of animals, nociceptive effects of toluene alone or co-administered with morphine were evaluated in the hot-plate test. Mice were exposed to toluene or TCE in static exposure chambers for 30 min, and their brains were removed 24 h later for autoradiography. Acute toluene inhalation produced a significant decrease in mu-opioid receptor binding levels in cingulate and piriform cortices, caudate putamen, thalamus, amygdala, and periaqueductal gray, whereas TCE significantly decreased mu-opioid receptor levels, but only in thalamus and periaqueductal gray. Both toluene and TCE decreased benzodiazepine receptor binding levels in discrete brain areas, but had no effect on NMDA receptor levels. In the hot-plate test, a single toluene exposure counteracted morphine antinociceptive response when the solvent exposure time was immediately followed by morphine treatment, but not when morphine was administered 24, 48, 72, and 96 h later. However, co-administration of morphine and toluene 24, 48, 72, and 96 h after the single solvent exposure resulted in morphine-induced analgesia blockade. Present results suggest that mu-opioid receptors are an important molecular target for organic solvents, and that the inhalation of these compounds may affect the analgesic properties of opioids.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18991886     DOI: 10.1196/annals.1432.031

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  8 in total

1.  Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization.

Authors:  Thierry Le Marec; Cynthia Marie-Claire; Florence Noble; Nicolas Marie
Journal:  Psychopharmacology (Berl)       Date:  2011-02-22       Impact factor: 4.530

2.  GABAA-positive modulator selective discriminative stimulus effects of 1,1,1-trichloroethane vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  Drug Alcohol Depend       Date:  2011-09-15       Impact factor: 4.492

Review 3.  Volatile substance misuse : clinical considerations, neuropsychopharmacology and potential role of pharmacotherapy in management.

Authors:  Eric L Garland; Matthew O Howard
Journal:  CNS Drugs       Date:  2012-11       Impact factor: 5.749

4.  Pharmacological characterization of the discriminative stimulus of inhaled 1,1,1-trichloroethane.

Authors:  Keith L Shelton
Journal:  J Pharmacol Exp Ther       Date:  2010-02-01       Impact factor: 4.030

5.  Negative allosteric modulation of GABAA receptors inhibits facilitation of brain stimulation reward by drugs of abuse in C57BL6/J mice.

Authors:  Matthew E Tracy; Matthew L Banks; Keith L Shelton
Journal:  Psychopharmacology (Berl)       Date:  2015-11-27       Impact factor: 4.530

6.  Pharmacological classification of the abuse-related discriminative stimulus effects of trichloroethylene vapor.

Authors:  Keith L Shelton; Katherine L Nicholson
Journal:  J Drug Alcohol Res       Date:  2014-03-01

Review 7.  The Neuroscience of Drug Reward and Addiction.

Authors:  Nora D Volkow; Michael Michaelides; Ruben Baler
Journal:  Physiol Rev       Date:  2019-10-01       Impact factor: 37.312

Review 8.  Finding possible pharmacological effects of identified organic compounds in medicinal waters (BTEX and phenolic compounds).

Authors:  István Szabó; Csaba Varga
Journal:  Int J Biometeorol       Date:  2019-10-31       Impact factor: 3.787

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.